Inhaled iloprost improved 6-minute walk distance from 105 m to 264 m and decreased systolic pulmonary arterial pressure from 64 mmHg to 45 mmHg over six months in a patient with cor pulmonale.
Case Report (n=1)
No
Chronic obstructive pulmonary disease (COPD) is one of the causes of cor pulmonale. Cor pulmonale patients with pulmonary hypertension have a significant lower survival rate than patients without. However, there is no conclusive treatment options in cor pulmonale and pulmonary hypertension associated with COPD until now. We report a patient with cor pulmonale and pulmonary hypertension associated with severe form of COPD and tuberculous destroyed lung who achieved marked clinical, functional and echocardiographic hemodynamic improvements with inhaled iloprost for six months.
Park et al. (Wed,) conducted a case report in Cor pulmonale and severe pulmonary hypertension associated with tuberculous destroyed lung (n=1). Inhaled iloprost was evaluated on Clinical, functional and echocardiographic hemodynamic improvements (6-minute walk test distance, WHO/NYHA class, systolic pulmonary arterial pressure). Inhaled iloprost improved 6-minute walk distance from 105 m to 264 m and decreased systolic pulmonary arterial pressure from 64 mmHg to 45 mmHg over six months in a patient with cor pulmonale.